Animal health is central to food security, public health, and environmental sustainability. The health of livestock, poultry, aquaculture species, and companion animals influences not only agricultural productivity but also zoonotic disease risks, trade dynamics, and the stability of food systems worldwide. Outbreaks of animal disease — whether highly pathogenic avian influenza, swine fever, or parasitic…

RSI supports organizations in developing robust BCP frameworks tailored to sector-specific risks and operational realities. RSI helps identify mission-critical activities, define acceptable downtime thresholds, and develop actionable recovery strategies. The firm emphasizes integration of BCP with enterprise risk management and regulatory expectations.

In a fast-moving risk environment, waiting to engage external expertise can cost valuable time and clarity. Organizations benefit from having pre-established access to risk specialists who already understand their operations, priorities, and constraints. When trusted advisors are standing by—briefed and ready—response times shrink, decision quality improves, and organizational resilience increases.

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments related to environmental contaminants and consumer products. His practice group supports government agencies, regulatory bodies, and international partners in making science-informed decisions that safeguard public health.

Blood and blood products are essential to modern healthcare, supporting surgeries, trauma care, cancer treatment, and the management of chronic diseases. Ensuring the safety and adequacy of the blood supply is therefore a critical public health priority. Risks arise from infectious disease transmission, donor eligibility challenges, storage and handling practices, and supply chain vulnerabilities. The…

To support the Chemicals Management Plan under the Canadian Environmental Protection Act (CEPA), Health Canada sought expert peer consultation for a draft screening assessment report (DSAR) evaluating 47 inorganic substances identified as priorities. The client required independent scientific and technical expertise to assess whether the report’s conclusions—particularly regarding health effects, exposure pathways, and risk characterizations—were sound, complete, and defensible.

RSI compiles and interprets toxicological data for use in chemical registration, public health policy, and safety evaluation. Its experts apply structure-activity relationships, mechanistic data, and systematic review techniques. RSI ensures that toxicological profiles are current, transparent, and adapted to the specific decision context.

RSI designs and facilitates participatory risk assessments that balance technical rigor with lived experience. It employs methods such as community workshops, co-design mapping, and structured deliberation. RSI ensures that local knowledge informs risk prioritization and that stakeholder concerns are reflected in actionable outcomes, especially in environmental health and climate resilience contexts.

RSI integrates psychosocial risk research into workplace risk assessments and community resilience projects. The firm designs ethically robust studies that capture stress-related risk factors and their impact on behavior, health, and systems performance. RSI emphasizes clarity in interpretation and supports decision-makers in addressing psychosocial risks alongside physical and chemical hazards.

RSI builds and interprets statistical models across a wide range of risk domains. Its statisticians collaborate with subject matter experts to ensure relevance, reliability, and transparency. RSI provides clear documentation of model design and assumptions, enabling clients to use results confidently in regulatory, operational, or strategic contexts.